In acute myeloid leukemia (AML) cells, HSF1 deletion downregulates succinate dehydrogenase C (SDHC) expression and suppresses the mitochondrial oxidative phosphorylation (OXPHOS), thereby inhibiting the growth of tumor cells (Fig. 3A) 108. The gene discussed is HSF1; the disease is neoplasm.